Zydus Lifesciences informs about press release

07 Jan 2025 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated January 7, 2025, titled ‘Zydus announces agreement with CVS Caremark to add ZituvioTM, ZituvimetTM and ZituvimetTM XR (Sitagliptin Sitagliptin and Metformin Hydrochloride) to its template formulary’.

The above information is a part of company’s filings submitted to BSE.



Zydus Lifesciences Share Price

910.75 5.90 (0.65%)
16-Feb-2026 11:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1701.00
Dr. Reddys Lab 1265.75
Cipla 1345.90
Zydus Lifesciences 910.75
Lupin 2226.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×